Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 113

1.

Prevalence of Mycoplasma genitalium in men with urethritis and in high risk asymptomatic males in Tel Aviv: a prospective study.

Gottesman T, Yossepowitch O, Samra Z, Rosenberg S, Dan M.

Int J STD AIDS. 2016 Jan 29. pii: 0956462416630675. [Epub ahead of print]

PMID:
26826161
2.

Orthotopic neobladder vs. ileal conduit urinary diversion: A long-term quality-of-life comparison.

Goldberg H, Baniel J, Mano R, Rotlevy G, Kedar D, Yossepowitch O.

Urol Oncol. 2016 Mar;34(3):121.e1-7. doi: 10.1016/j.urolonc.2015.10.006. Epub 2015 Dec 3.

PMID:
26670201
3.

Escherichia coli isolates from patients with bacteremic urinary tract infection are genetically distinct from those derived from sepsis following prostate transrectal biopsy.

Dan M, Yair Y, Samosav A, Gottesman T, Yossepowitch O, Harari-Schwartz O, Tsivian A, Schreiber R, Gophna U.

Int J Med Microbiol. 2015 Jun-Aug;305(4-5):464-8. doi: 10.1016/j.ijmm.2015.04.003. Epub 2015 Apr 25.

PMID:
25963574
4.

Systematic ultrasound-guided saturation and template biopsy of the prostate: indications and advantages of extended sampling.

Isbarn H, Briganti A, De Visschere PJ, Fütterer JJ, Ghadjar P, Giannarini G, Ost P, Ploussard G, Sooriakumaran P, Surcel CI, van Oort IM, Yossepowitch O, van den Bergh RC; Prostate Cancer Working Group of the European Association of Urology Young Academic Urologists.

Arch Esp Urol. 2015 Apr;68(3):296-306.

PMID:
25948801
5.
6.

Prognostic effect of neuroendocrine differentiation in prostate cancer: A critical review.

Surcel CI, van Oort IM, Sooriakumaran P, Briganti A, De Visschere PJ, Fütterer JJ, Ghadjar P, Isbarn H, Ost P, van den Bergh RC, Yossepowitch O, Giannarini G, Ploussard G; Members of the Prostate Cancer Working Group of the Young Academic Urologists Working Party of the European Association of Urology.

Urol Oncol. 2015 Jun;33(6):265.e1-7. doi: 10.1016/j.urolonc.2014.08.007. Epub 2014 Sep 17. Review.

PMID:
25238700
7.

Active surveillance cultures in critically ill patients: pathogens, patterns, and correlation with eventual bloodstream infections.

Soroksky A, Nagornov S, Klinowski E, Leonov Y, Ilgiyaev E, Yossepowitch O, Goltsman G.

Isr Med Assoc J. 2014 Jul;16(7):418-22.

8.

Can we expand active surveillance criteria to include biopsy Gleason 3+4 prostate cancer? A multi-institutional study of 2,323 patients.

Ploussard G, Isbarn H, Briganti A, Sooriakumaran P, Surcel CI, Salomon L, Freschi M, Mirvald C, van der Poel HG, Jenkins A, Ost P, van Oort IM, Yossepowitch O, Giannarini G, van den Bergh RC; Members of the Prostate Cancer Working Group of the Young Academic Urologists Working Party of the European Association of Urology.

Urol Oncol. 2015 Feb;33(2):71.e1-9. doi: 10.1016/j.urolonc.2014.07.007. Epub 2014 Aug 15.

PMID:
25131660
9.

Personalized prostate cancer screening among men with high risk genetic predisposition- study protocol for a prospective cohort study.

Margel D, Benjaminov O, Ozalvo R, Shavit Grievink L, Kedar I, Yerushalmi R, Ben-Aharon I, Neiman V, Yossepowitch O, Kedar D, Levy Z, Shohat M, Brenner B, Baniel J, Rosenbaum E.

BMC Cancer. 2014 Jul 21;14:528. doi: 10.1186/1471-2407-14-528.

10.

The oncologic role of local treatment in primary metastatic prostate cancer.

Ghadjar P, Briganti A, De Visschere PJ, Fütterer JJ, Giannarini G, Isbarn H, Ost P, Sooriakumaran P, Surcel CI, van den Bergh RC, van Oort IM, Yossepowitch O, Ploussard G.

World J Urol. 2015 Jun;33(6):755-61. doi: 10.1007/s00345-014-1347-9. Epub 2014 Jul 5. Review.

PMID:
24997127
11.

A novel urine cytology stain for the detection and monitoring of bladder cancer.

Davis N, Mor Y, Idelevich P, Terkieltaub D, Ziv V, Elkeles A, Lew S, Okon E, Laufer M, Ramon J, Kedar D, Baniel J, Yossepowitch O.

J Urol. 2014 Dec;192(6):1628-32. doi: 10.1016/j.juro.2014.06.079. Epub 2014 Jun 30.

PMID:
24992334
12.

The accuracy of Gram stain of respiratory specimens in excluding Staphylococcus aureus in ventilator-associated pneumonia.

Gottesman T, Yossepowitch O, Lerner E, Schwartz-Harari O, Soroksky A, Yekutieli D, Dan M.

J Crit Care. 2014 Oct;29(5):739-42. doi: 10.1016/j.jcrc.2014.05.011. Epub 2014 May 28.

PMID:
24973104
13.

Salvage lymph node dissection for biochemical recurrence following radical prostatectomy: is the evidence there?

Yossepowitch O.

Eur Urol. 2015 May;67(5):850-1. doi: 10.1016/j.eururo.2014.04.021. Epub 2014 May 2. No abstract available.

PMID:
24813270
14.

Preferences in the management of high-risk prostate cancer among urologists in Europe: results of a web-based survey.

Surcel CI, Sooriakumaran P, Briganti A, De Visschere PJ, Fütterer JJ, Ghadjar P, Isbarn H, Ost P, Ploussard G, van den Bergh RC, van Oort IM, Yossepowitch O, Sedelaar JP, Giannarini G; Members of Prostate Cancer Working Group of Young Academic Urologists Working Party; Members of Young Urologists Office of European Association of Urology.

BJU Int. 2015 Apr;115(4):571-9. doi: 10.1111/bju.12796. Epub 2014 Aug 11.

15.

A cost-saving algorithm for rapid diagnosis of Staphylococcus aureus and susceptibility to oxacillin directly from positive blood culture bottles by combined testing with BinaxNOW® S. aureus and Xpert MRSA/SA Assay.

Yossepowitch O, Dan M, Kutchinsky A, Gottesman T, Schwartz-Harari O.

Diagn Microbiol Infect Dis. 2014 Apr;78(4):352-5. doi: 10.1016/j.diagmicrobio.2014.01.001. Epub 2014 Jan 10.

PMID:
24503507
16.

Low-dose oral desmopressin for treatment of nocturia and nocturnal enuresis in patients after radical cystectomy and orthotopic urinary diversion.

Goldberg H, Baniel J, Mano R, Gillon G, Kedar D, Yossepowitch O.

BJU Int. 2014 Nov;114(5):727-32. doi: 10.1111/bju.12598. Epub 2014 Jul 27.

17.

Urinary tract infections in patients with orthotopic neobladder.

Mano R, Baniel J, Goldberg H, Stabholz Y, Kedar D, Yossepowitch O.

Urol Oncol. 2014 Jan;32(1):50.e9-14. doi: 10.1016/j.urolonc.2013.07.017. Epub 2013 Nov 13.

PMID:
24239471
18.

Positive surgical margins after radical prostatectomy: a systematic review and contemporary update.

Yossepowitch O, Briganti A, Eastham JA, Epstein J, Graefen M, Montironi R, Touijer K.

Eur Urol. 2014 Feb;65(2):303-13. doi: 10.1016/j.eururo.2013.07.039. Epub 2013 Aug 3. Review.

PMID:
23932439
19.

Presence of detrusor muscle in bladder tumor specimens--predictors and effect on outcome as a measure of resection quality.

Shoshany O, Mano R, Margel D, Baniel J, Yossepowitch O.

Urol Oncol. 2014 Jan;32(1):40.e17-22. doi: 10.1016/j.urolonc.2013.04.009. Epub 2013 Aug 2.

PMID:
23911682
20.

Empiric antibiotics for an elevated prostate-specific antigen (PSA) level: a randomised, prospective, controlled multi-institutional trial.

Eggener SE, Large MC, Gerber GS, Pettus J, Yossepowitch O, Smith ND, Kundu S, Kunnavakkam R, Zorn K, Raman JD.

BJU Int. 2013 Nov;112(7):925-9. doi: 10.1111/bju.12241. Epub 2013 Jul 26.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk